Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
Identifieur interne : 002897 ( Main/Exploration ); précédent : 002896; suivant : 002898Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
Auteurs : Merlin C. Thomas [Australie] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; Qiang Li [Australie] ; Raelene Pickering [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Vlado Perkovic [Australie] ; Mark E. Cooper [Australie] ; Sophia Zoungas [Australie] ; John Chalmers [Australie] ; Graham S. Hillis [Australie]Source :
- Diabetes care [ 1935-5548 ] ; 2015.
Descripteurs français
- KwdFr :
- Angiopathies diabétiques (), Angiopathies diabétiques (métabolisme), Association de médicaments, Diabète de type 2 (), Diabète de type 2 (métabolisme), Femelle, Humains, Hypoglycémiants (administration et posologie), Marqueurs biologiques (métabolisme), Mâle, Méthode en double aveugle, Méthodes épidémiologiques, Néphropathies diabétiques (), Néphropathies diabétiques (métabolisme), Produits terminaux de glycation avancée (métabolisme), Récepteur spécifique des produits finaux de glycosylation avancée (métabolisme), Récepteurs immunologiques, Résultat thérapeutique, Sujet âgé.
- MESH :
- administration et posologie : Hypoglycémiants.
- métabolisme : Angiopathies diabétiques, Diabète de type 2, Marqueurs biologiques, Néphropathies diabétiques, Produits terminaux de glycation avancée, Récepteur spécifique des produits finaux de glycosylation avancée.
- Angiopathies diabétiques, Association de médicaments, Diabète de type 2, Femelle, Humains, Mâle, Méthode en double aveugle, Méthodes épidémiologiques, Néphropathies diabétiques, Récepteurs immunologiques, Résultat thérapeutique, Sujet âgé.
English descriptors
- KwdEn :
- Advanced Glycosylation End Product-Specific Receptor (metabolism), Aged, Biomarkers (metabolism), Diabetes Mellitus, Type 2 (metabolism), Diabetes Mellitus, Type 2 (prevention & control), Diabetic Angiopathies (metabolism), Diabetic Angiopathies (prevention & control), Diabetic Nephropathies (metabolism), Diabetic Nephropathies (prevention & control), Double-Blind Method, Drug Therapy, Combination, Epidemiologic Methods, Female, Glycosylation End Products, Advanced (metabolism), Humans, Hypoglycemic Agents (administration & dosage), Male, Receptors, Immunologic, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Hypoglycemic Agents.
- chemical , metabolism : Advanced Glycosylation End Product-Specific Receptor, Biomarkers, Glycosylation End Products, Advanced.
- metabolism : Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies.
- prevention & control : Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies.
- Aged, Double-Blind Method, Drug Therapy, Combination, Epidemiologic Methods, Female, Humans, Male, Receptors, Immunologic, Treatment Outcome.
Abstract
This study explored whether activation of the receptor for advanced glycation end products (RAGE) is implicated in the development of diabetes complications.
DOI: 10.2337/dc15-0925
PubMed: 26253728
Affiliations:
- Australie, France, Royaume-Uni
- Angleterre, Grand Londres, Maryland, Nouvelle-Galles du Sud, Île-de-France
- Baltimore, Londres, Paris, Sydney
- Université de Sydney
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002906
- to stream PubMed, to step Curation: 002837
- to stream PubMed, to step Checkpoint: 002837
- to stream Ncbi, to step Merge: 002920
- to stream Ncbi, to step Curation: 002920
- to stream Ncbi, to step Checkpoint: 002920
- to stream Main, to step Merge: 002897
- to stream Main, to step Curation: 002897
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.</title><author><name sortKey="Thomas, Merlin C" sort="Thomas, Merlin C" uniqKey="Thomas M" first="Merlin C" last="Thomas">Merlin C. Thomas</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore, MD markw@georgeinstitute.org.au.</nlm:affiliation><country wicri:rule="url">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Li, Qiang" sort="Li, Qiang" uniqKey="Li Q" first="Qiang" last="Li">Qiang Li</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Pickering, Raelene" sort="Pickering, Raelene" uniqKey="Pickering R" first="Raelene" last="Pickering">Raelene Pickering</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="3"><nlm:affiliation>University College London and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University College London and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Perkovic, Vlado" sort="Perkovic, Vlado" uniqKey="Perkovic V" first="Vlado" last="Perkovic">Vlado Perkovic</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Cooper, Mark E" sort="Cooper, Mark E" uniqKey="Cooper M" first="Mark E" last="Cooper">Mark E. Cooper</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Hillis, Graham S" sort="Hillis, Graham S" uniqKey="Hillis G" first="Graham S" last="Hillis">Graham S. Hillis</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia Department of Cardiology, Royal Perth Hospital, Perth, Western Australia</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26253728</idno><idno type="pmid">26253728</idno><idno type="doi">10.2337/dc15-0925</idno><idno type="wicri:Area/PubMed/Corpus">002906</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002906</idno><idno type="wicri:Area/PubMed/Curation">002837</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002837</idno><idno type="wicri:Area/PubMed/Checkpoint">002837</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002837</idno><idno type="wicri:Area/Ncbi/Merge">002920</idno><idno type="wicri:Area/Ncbi/Curation">002920</idno><idno type="wicri:Area/Ncbi/Checkpoint">002920</idno><idno type="wicri:Area/Main/Merge">002897</idno><idno type="wicri:Area/Main/Curation">002897</idno><idno type="wicri:Area/Main/Exploration">002897</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.</title><author><name sortKey="Thomas, Merlin C" sort="Thomas, Merlin C" uniqKey="Thomas M" first="Merlin C" last="Thomas">Merlin C. Thomas</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore, MD markw@georgeinstitute.org.au.</nlm:affiliation><country wicri:rule="url">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, Nuffield Department of Population Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore</wicri:regionArea><placeName><settlement type="city">Baltimore</settlement><region type="state">Maryland</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Li, Qiang" sort="Li, Qiang" uniqKey="Li Q" first="Qiang" last="Li">Qiang Li</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Pickering, Raelene" sort="Pickering, Raelene" uniqKey="Pickering R" first="Raelene" last="Pickering">Raelene Pickering</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hôpital Bichat-Claude Bernard and Université Paris 7, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="3"><nlm:affiliation>University College London and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>University College London and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Perkovic, Vlado" sort="Perkovic, Vlado" uniqKey="Perkovic V" first="Vlado" last="Perkovic">Vlado Perkovic</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Cooper, Mark E" sort="Cooper, Mark E" uniqKey="Cooper M" first="Mark E" last="Cooper">Mark E. Cooper</name><affiliation wicri:level="1"><nlm:affiliation>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Baker IDI Heart & Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Hillis, Graham S" sort="Hillis, Graham S" uniqKey="Hillis G" first="Graham S" last="Hillis">Graham S. Hillis</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia Department of Cardiology, Royal Perth Hospital, Perth, Western Australia</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></analytic><series><title level="j">Diabetes care</title><idno type="eISSN">1935-5548</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Advanced Glycosylation End Product-Specific Receptor (metabolism)</term><term>Aged</term><term>Biomarkers (metabolism)</term><term>Diabetes Mellitus, Type 2 (metabolism)</term><term>Diabetes Mellitus, Type 2 (prevention & control)</term><term>Diabetic Angiopathies (metabolism)</term><term>Diabetic Angiopathies (prevention & control)</term><term>Diabetic Nephropathies (metabolism)</term><term>Diabetic Nephropathies (prevention & control)</term><term>Double-Blind Method</term><term>Drug Therapy, Combination</term><term>Epidemiologic Methods</term><term>Female</term><term>Glycosylation End Products, Advanced (metabolism)</term><term>Humans</term><term>Hypoglycemic Agents (administration & dosage)</term><term>Male</term><term>Receptors, Immunologic</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Angiopathies diabétiques ()</term><term>Angiopathies diabétiques (métabolisme)</term><term>Association de médicaments</term><term>Diabète de type 2 ()</term><term>Diabète de type 2 (métabolisme)</term><term>Femelle</term><term>Humains</term><term>Hypoglycémiants (administration et posologie)</term><term>Marqueurs biologiques (métabolisme)</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Méthodes épidémiologiques</term><term>Néphropathies diabétiques ()</term><term>Néphropathies diabétiques (métabolisme)</term><term>Produits terminaux de glycation avancée (métabolisme)</term><term>Récepteur spécifique des produits finaux de glycosylation avancée (métabolisme)</term><term>Récepteurs immunologiques</term><term>Résultat thérapeutique</term><term>Sujet âgé</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Hypoglycemic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Advanced Glycosylation End Product-Specific Receptor</term><term>Biomarkers</term><term>Glycosylation End Products, Advanced</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Hypoglycémiants</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Diabetic Angiopathies</term><term>Diabetic Nephropathies</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Angiopathies diabétiques</term><term>Diabète de type 2</term><term>Marqueurs biologiques</term><term>Néphropathies diabétiques</term><term>Produits terminaux de glycation avancée</term><term>Récepteur spécifique des produits finaux de glycosylation avancée</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Diabetic Angiopathies</term><term>Diabetic Nephropathies</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Double-Blind Method</term><term>Drug Therapy, Combination</term><term>Epidemiologic Methods</term><term>Female</term><term>Humans</term><term>Male</term><term>Receptors, Immunologic</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Angiopathies diabétiques</term><term>Association de médicaments</term><term>Diabète de type 2</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Méthodes épidémiologiques</term><term>Néphropathies diabétiques</term><term>Récepteurs immunologiques</term><term>Résultat thérapeutique</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study explored whether activation of the receptor for advanced glycation end products (RAGE) is implicated in the development of diabetes complications.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Maryland</li><li>Nouvelle-Galles du Sud</li><li>Île-de-France</li></region><settlement><li>Baltimore</li><li>Londres</li><li>Paris</li><li>Sydney</li></settlement><orgName><li>Université de Sydney</li></orgName></list><tree><country name="Australie"><noRegion><name sortKey="Thomas, Merlin C" sort="Thomas, Merlin C" uniqKey="Thomas M" first="Merlin C" last="Thomas">Merlin C. Thomas</name></noRegion><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><name sortKey="Cooper, Mark E" sort="Cooper, Mark E" uniqKey="Cooper M" first="Mark E" last="Cooper">Mark E. Cooper</name><name sortKey="Hillis, Graham S" sort="Hillis, Graham S" uniqKey="Hillis G" first="Graham S" last="Hillis">Graham S. Hillis</name><name sortKey="Li, Qiang" sort="Li, Qiang" uniqKey="Li Q" first="Qiang" last="Li">Qiang Li</name><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name><name sortKey="Perkovic, Vlado" sort="Perkovic, Vlado" uniqKey="Perkovic V" first="Vlado" last="Perkovic">Vlado Perkovic</name><name sortKey="Pickering, Raelene" sort="Pickering, Raelene" uniqKey="Pickering R" first="Raelene" last="Pickering">Raelene Pickering</name><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name></country><country name="France"><region name="Île-de-France"><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002897 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002897 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26253728
|texte= Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26253728" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |